The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — The French pharma company ...

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...

In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to full ...

Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...

Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...

Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot ...

At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions about ...

Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their ...

A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S.